Therapy-related acute promyelocytic leukemia (t-APL) is rare and often linked to previous treatment with alkylating agents or topoisomerase II inhibitors. This report describes three cases of t-APL ...

Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence of ...

New technology that rapidly and simply detects disease-specific molecular alterations in two forms of leukemia could give ...

Blood cancer is not always fatal and advancements in treatment offer significant hope. Misconceptions exist, such as it being ...

Rapid blood cancer diagnostics enable faster decision-making, potentially saving lives by providing quicker, more accurate ...

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions.

BEIJING, Sept. 29 (Xinhua) -- The year 2024 is meant to be an important year for Chinese doctor Wang Zhenyi. Turning 100 this year, the celebrated medical scientist has been conferred the Medal of the ...